ES394919A1 - 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes - Google Patents

1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes

Info

Publication number
ES394919A1
ES394919A1 ES394919A ES394919A ES394919A1 ES 394919 A1 ES394919 A1 ES 394919A1 ES 394919 A ES394919 A ES 394919A ES 394919 A ES394919 A ES 394919A ES 394919 A1 ES394919 A1 ES 394919A1
Authority
ES
Spain
Prior art keywords
group
carbon atoms
halogen atom
see formula
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES394919A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Publication of ES394919A1 publication Critical patent/ES394919A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/53—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton
    • E—FIXED CONSTRUCTIONS
    • E04—BUILDING
    • E04H—BUILDINGS OR LIKE STRUCTURES FOR PARTICULAR PURPOSES; SWIMMING OR SPLASH BATHS OR POOLS; MASTS; FENCING; TENTS OR CANOPIES, IN GENERAL
    • E04H13/00—Monuments; Tombs; Burial vaults; Columbaria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Architecture (AREA)
  • Civil Engineering (AREA)
  • Structural Engineering (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedure for the preparation of new racemic or optically active 1-phenoxy-2-hydroxy-3-alcoholylaminopropanes of the general formula ** (See formula) ** where R means an alcohol group with 1 to 5 carbon atoms; R1 means a nitrile group (See formula) carboxy, hydroxy, amino, nitro or trifluoromethyl or an alkyl, alkenyl, alkynyl, alkoxy, alkenyloxy, alkynyloxy, hydroxyalkyl, alcoxialcohilo, aminoalcohilo, alcohilaminoalcohilo, dialcohilaminoalcohilo, alkylamino, dialkylamino, nitriloalcohilo, alkoxycarbonyl, alcohilaminocarbonilo, alkylthio, acyl, acyloxy, or acylamino with up to 5 carbon atoms, an aryl, aralkoxy, aryloxy, aralkoxy, or arylamino group with up to 10 carbon atoms or a halogen atom; R2 means hydrogen, a halogen atom, a nitrile group or an alcoholic, alkoxy or alkenyl group with up to 5 carbon atoms or together with R1 a 3,4-methylenedioxy group (without other substituents); R3 means hydrogen, a halogen atom, an alcohol or alkoxy group with up to 5 carbon atoms; and n signifies an integer from 2 to 7, as well as its physiologically compatible acid addition salts, characterized in that in a compound of the general formula ** (See formula) ** in which R and n have the meanings mentioned above and Ar means the radical ** (See formula) ** or the radical ** (See formula) ** (in which R and R3 or R1 and R2 have the aforementioned meanings) a halogen atom is introduced, and by which the racemic compounds obtained from formula I are eventually transformed, by reaction with appropriate auxiliary acids, into their diastereoisomeric salts, and the latter are separated by fractional crystallization. (Machine-translation by Google Translate, not legally binding)
ES394919A 1969-07-23 1971-09-09 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes Expired ES394919A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1937477A DE1937477C3 (en) 1969-07-23 1969-07-23 I-phenoxy-2-hydroxy-3- (l -methylcycloalkylamino) propane, process for their preparation and medicaments containing them

Publications (1)

Publication Number Publication Date
ES394919A1 true ES394919A1 (en) 1974-12-01

Family

ID=5740681

Family Applications (8)

Application Number Title Priority Date Filing Date
ES382014A Expired ES382014A1 (en) 1969-07-23 1970-07-21 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes
ES394916A Expired ES394916A1 (en) 1969-07-23 1971-09-09 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes
ES394915A Expired ES394915A1 (en) 1969-07-23 1971-09-09 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes
ES394917A Expired ES394917A1 (en) 1969-07-23 1971-09-09 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes
ES394913A Expired ES394913A1 (en) 1969-07-23 1971-09-09 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes
ES394918A Expired ES394918A1 (en) 1969-07-23 1971-09-09 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes
ES394919A Expired ES394919A1 (en) 1969-07-23 1971-09-09 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes
ES394914A Expired ES394914A1 (en) 1969-07-23 1971-09-09 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes

Family Applications Before (6)

Application Number Title Priority Date Filing Date
ES382014A Expired ES382014A1 (en) 1969-07-23 1970-07-21 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes
ES394916A Expired ES394916A1 (en) 1969-07-23 1971-09-09 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes
ES394915A Expired ES394915A1 (en) 1969-07-23 1971-09-09 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes
ES394917A Expired ES394917A1 (en) 1969-07-23 1971-09-09 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes
ES394913A Expired ES394913A1 (en) 1969-07-23 1971-09-09 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes
ES394918A Expired ES394918A1 (en) 1969-07-23 1971-09-09 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES394914A Expired ES394914A1 (en) 1969-07-23 1971-09-09 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes

Country Status (17)

Country Link
US (1) US3755413A (en)
JP (5) JPS5133106B1 (en)
AT (9) AT306703B (en)
BE (1) BE753774A (en)
BG (9) BG17508A3 (en)
CH (10) CH536810A (en)
CS (9) CS170530B2 (en)
DE (1) DE1937477C3 (en)
DK (1) DK140281B (en)
ES (8) ES382014A1 (en)
FR (1) FR2059551B1 (en)
GB (1) GB1314896A (en)
NL (1) NL169874C (en)
PL (9) PL90030B1 (en)
RO (9) RO59159A (en)
SE (1) SE370391B (en)
YU (5) YU34395B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021576A (en) * 1969-07-23 1977-05-03 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing a 1-(2'-ethynyl-phenoxy)-2-hydroxy-3-(cycloalkyl-amino)-propane and method of use
US3937706A (en) * 1969-07-23 1976-02-10 Boehringer Ingelheim Gmbh 1-(2'ethynyl-phenoxy)-2-hydroxy-3-(cycloalkyl-amino)-propanes and salts thereof
US4038313A (en) * 1970-01-08 1977-07-26 Ciba-Geigy Corporation Cycloalkylureido phenoxy propanolamines
US4120978A (en) * 1970-01-08 1978-10-17 Ciba-Geigy Corporation Pharmaceutical composition for inhibiting and blocking cardioselective beta-receptors
SE354851B (en) * 1970-02-18 1973-03-26 Haessle Ab
US4145442A (en) * 1972-04-04 1979-03-20 Aktiebolaget Hassle Phenoxy-hydroxypropylamines, their preparation, and method and pharmaceutical preparations for treating cardiovascular diseases
US4038414A (en) * 1972-06-08 1977-07-26 Ciba-Geigy Corporation Amines and processes for their manufacture
US4035420A (en) * 1972-07-06 1977-07-12 Aktiebolaget Hassle Substituted ureido alkylene phenoxy propanolamines
DE2309887C2 (en) * 1973-02-28 1983-11-10 C.H. Boehringer Sohn, 6507 Ingelheim 1-aryloxy-2-hydroxy-3-alkynylaminopropane derivatives and their physiologically acceptable acid addition salts, pharmaceutical preparations and manufacturing processes for the compounds
US4220659A (en) * 1974-02-22 1980-09-02 Boehringer Ingelheim Gmbh 1-Phenoxy-2-hydroxy-3-alkynylamino-propanes and salts thereof
SE7510153L (en) * 1974-09-12 1976-05-07 American Cyanamid Co ALKANOLAMINES
US4165384A (en) * 1974-11-01 1979-08-21 Aktiebolaget Hassle Amide substituted phenoxy propanol amines
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4471127A (en) * 1981-09-08 1984-09-11 Ciba-Geigy Corporation 1-5-Bis-(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols
US5039801A (en) * 1985-12-20 1991-08-13 The United States Of America As Represented By The Department Of Health & Human Services Thermal fragmentation of methylbenzylurea disastereomers or secondary amines and preparation of optically active secondary amines
JPS6364630U (en) * 1986-10-17 1988-04-28

Also Published As

Publication number Publication date
PL90026B1 (en) 1976-12-31
YU254675A (en) 1979-04-30
AT303706B (en) 1972-12-11
CH536810A (en) 1973-06-29
PL79772B1 (en) 1975-06-30
NL7010928A (en) 1971-01-26
RO60112A (en) 1976-08-15
YU34662B (en) 1979-12-31
DE1937477C3 (en) 1980-04-10
JPS5210861B1 (en) 1977-03-26
CH536812A (en) 1973-06-29
BG17505A3 (en) 1973-11-10
YU254475A (en) 1978-12-31
YU34395B (en) 1979-07-10
FR2059551A1 (en) 1971-06-04
RO59112A (en) 1976-01-15
SE370391B (en) 1974-10-14
AT304478B (en) 1973-01-10
CS170527B2 (en) 1976-08-27
PL90028B1 (en) 1976-12-31
PL90027B1 (en) 1976-12-31
PL90029B1 (en) 1976-12-31
AT306703B (en) 1973-04-25
PL90030B1 (en) 1976-12-31
ES394914A1 (en) 1974-12-01
CH575376A5 (en) 1976-05-14
CS170524B2 (en) 1976-08-27
AT304475B (en) 1973-01-10
PL90038B1 (en) 1976-12-31
DE1937477A1 (en) 1971-02-04
PL90039B1 (en) 1976-12-31
AT306704B (en) 1973-04-25
YU34396B (en) 1979-07-10
CS170532B2 (en) 1976-08-27
AT304476B (en) 1973-01-10
YU34663B (en) 1979-12-31
RO59089A (en) 1975-11-15
CH536809A (en) 1973-06-29
BG19132A3 (en) 1975-04-30
CS170528B2 (en) 1976-08-27
BG18852A3 (en) 1975-03-20
JPS5133106B1 (en) 1976-09-17
RO59211A (en) 1976-01-15
BG17507A3 (en) 1973-11-10
YU255175A (en) 1978-06-30
DK140281B (en) 1979-07-23
FR2059551B1 (en) 1974-09-20
BG17749A3 (en) 1973-12-25
RO59210A (en) 1976-01-15
ES394913A1 (en) 1974-12-16
CS170531B2 (en) 1976-08-27
GB1314896A (en) 1973-04-26
BE753774A (en) 1971-01-22
RO56318A (en) 1974-09-01
NL169874B (en) 1982-04-01
BG17750A3 (en) 1973-12-25
ES394916A1 (en) 1974-12-16
ES382014A1 (en) 1973-06-16
CS170526B2 (en) 1976-08-27
RO59159A (en) 1976-02-15
YU254575A (en) 1979-04-30
CH550139A (en) 1974-06-14
US3755413A (en) 1973-08-28
NL169874C (en) 1982-09-01
CH550140A (en) 1974-06-14
AT306702B (en) 1973-04-25
BG17506A3 (en) 1973-11-10
CH570363A5 (en) 1975-12-15
BG17751A3 (en) 1973-12-25
YU34113B (en) 1978-12-31
CH536811A (en) 1973-06-29
AT304477B (en) 1973-01-10
DK140281C (en) 1979-12-10
ES394918A1 (en) 1974-12-01
JPS5210863B1 (en) 1977-03-26
CH536813A (en) 1973-06-29
CS170525B2 (en) 1976-08-27
ES394915A1 (en) 1974-12-16
RO60111A (en) 1976-06-15
BG17508A3 (en) 1973-11-10
DE1937477B2 (en) 1979-08-02
YU186070A (en) 1978-12-31
RO59209A (en) 1976-01-15
CS170529B2 (en) 1976-08-27
JPS5210862B1 (en) 1977-03-26
JPS5238556B1 (en) 1977-09-29
CH537360A (en) 1973-05-31
CS170530B2 (en) 1976-08-27
ES394917A1 (en) 1974-12-01
AT304474B (en) 1973-01-10
PL90025B1 (en) 1976-12-31

Similar Documents

Publication Publication Date Title
ES394919A1 (en) 1-cyanophenoxy-2-hydroxy-3-(cycloalkyl-amino)-propanes
ES396213A1 (en) N-(1-bicyclic aryl-propyl-2)-n'-bicyclic aryl-piperazines
ES419935A1 (en) 1-hydroxy-1-((4'-hydroxy-3'aminosulfonamido)-phenyl)-2-amino-ethanes and salts
ES399868A1 (en) 1-phenoxy-2-hydroxy-3-hydroxyalkylamino-propanes an processes for their preparation
ES446126A1 (en) 2-(phenoxyalkylthio)imidazoles and congeners
ES320729A1 (en) Procedure for the synthesis of new derivatives of antranilic acid. (Machine-translation by Google Translate, not legally binding)
ES554827A0 (en) PROCEDURE FOR PREPARING HEXENOIC ACIDS.
ES8601910A1 (en) New amidine derivatives of 2-substituted 4-phenilimidazole.
ES396174A1 (en) Phenylethanolamine derivatives
ES446699A1 (en) Biphenyl derivatives and pharmaceutical compositions thereof
ES387136A1 (en) Benzodiazepines the preparation thereof and compositions containing the same
ES454657A1 (en) Triaryl or diarylpyridyl methanes
ES442024A1 (en) Phenylpropanolamines
ES423226A1 (en) Procedure for the preparation of new 1,4-benzodiazepinas. (Machine-translation by Google Translate, not legally binding)
ES423746A1 (en) Procedure for preparing 2-aminoindane derivatives. (Machine-translation by Google Translate, not legally binding)
ES8201160A1 (en) 10-Bromosandwicine and 10-bromoisosandwicine, as well as their additions salts with pharmacolical acceptable acids process for their preparation and their use.
ES379734A1 (en) Procedure for the preparation of new 1 - fenoxy-2- hydroxy-3-sec-alcohilaminopropanos racemicos or optically active. (Machine-translation by Google Translate, not legally binding)
ES432464A1 (en) Substituted 4-biphenylyl-butenoic acids esters and amides and pharmaceutical compositions containing them
ES379732A1 (en) Procedure for the preparation of new 1-phenoxy-2-hydroxy-3-sec-alcohilaminopranos racemicos or optically active. (Machine-translation by Google Translate, not legally binding)
ES427582A1 (en) Benzoyl-benzoic acid derivatives
ES366913A1 (en) A procedure for the preparation of therapeutically active substitute cyclohexanes. (Machine-translation by Google Translate, not legally binding)
ES369545A1 (en) Procedure for the preparation of new 1-phenoxy-2-hydroxy-3-alcohilaminopropanos substituted, racemic or optically active. (Machine-translation by Google Translate, not legally binding)
ES8207535A1 (en) A procedure for the preparation of imidazodiacepine derivatives (Machine-translation by Google Translate, not legally binding)
AR241490A1 (en) {bis(hydroxymethyl)-methyl]-isoquinoline derivatives, process for preparing them and pharmaceutical compositions containing them
ES301630A1 (en) A procedure for preparing a substitute acid amid. (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19850322